Inovio Pharmaceuticals, Inc. (INO)
1.215
+0.06
(+5.65%)
USD |
NASDAQ |
Sep 17, 13:37
Inovio Pharmaceuticals Market Cap : 100.05M for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 94.69M |
| September 15, 2026 | 95.52M |
| September 14, 2026 | 97.16M |
| September 11, 2026 | 102.93M |
| September 10, 2026 | 105.40M |
| September 09, 2026 | 108.69M |
| September 08, 2026 | 116.93M |
| September 04, 2026 | 117.75M |
| September 03, 2026 | 111.98M |
| September 02, 2026 | 111.98M |
| September 01, 2026 | 109.51M |
| August 31, 2026 | 104.57M |
| August 28, 2026 | 106.22M |
| August 27, 2026 | 103.75M |
| August 26, 2026 | 107.04M |
| August 25, 2026 | 106.22M |
| August 24, 2026 | 102.93M |
| August 21, 2026 | 97.16M |
| August 20, 2026 | 99.63M |
| August 19, 2026 | 107.04M |
| August 18, 2026 | 98.81M |
| August 17, 2026 | 94.69M |
| August 14, 2026 | 89.75M |
| August 13, 2026 | 74.12M |
| August 12, 2026 | 63.40M |
| Date | Value |
|---|---|
| August 11, 2026 | 63.06M |
| August 10, 2026 | 60.64M |
| August 07, 2026 | 46.61M |
| August 06, 2026 | 47.01M |
| August 05, 2026 | 47.24M |
| August 04, 2026 | 46.27M |
| August 03, 2026 | 48.62M |
| July 31, 2026 | 47.24M |
| July 30, 2026 | 45.77M |
| July 29, 2026 | 72.56M |
| July 28, 2026 | 71.87M |
| July 27, 2026 | 67.34M |
| July 24, 2026 | 67.69M |
| July 23, 2026 | 71.17M |
| July 22, 2026 | 73.96M |
| July 21, 2026 | 76.75M |
| July 20, 2026 | 76.05M |
| July 17, 2026 | 78.15M |
| July 16, 2026 | 78.15M |
| July 15, 2026 | 81.63M |
| July 14, 2026 | 80.94M |
| July 13, 2026 | 80.94M |
| July 10, 2026 | 82.33M |
| July 09, 2026 | 83.03M |
| July 08, 2026 | 84.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Fortress Biotech, Inc. | 83.11M |
| Tonix Pharmaceuticals Holding Corp. | 191.43M |
| Kura Oncology, Inc. | 1.053B |
| Spero Therapeutics, Inc. | 65.12M |
| ACADIA Pharmaceuticals, Inc. | 4.728B |
Market Cap Related Metrics
| Price to Book Value | 22.89 |
| Price | 1.215 |
| Earnings Yield | -96.79% |